Healthcare Industry News: Inverness Medical Innovations
News Release - January 8, 2008
Third Wave Announces First European HPV Distribution PartnersMADISON, Wis.--(HSMN NewsFeed)--Third Wave Technologies Inc. (NASDAQ: TWTI ) today announced that Inverness Medical Iberica, the Spanish affiliate of Inverness Medical Innovations, will distribute Third Wave’s HPV high-risk screening test in Spain and Portugal. Inverness Medical Iberica is a leader in the marketing of diagnostics to assist laboratory and health care professionals in both preventive and interventional medicine.
Third Wave also announced that four well-known regional distributors have been secured to distribute its HPV product in Italy.
“Third Wave has taken another significant step forward in our HPV commercialization plans with the appointment of our first European HPV test distributors,” said Kevin T. Conroy, president and chief executive of Third Wave. “Inverness Medical Iberica provides Third Wave with a well-established, substantial sales force in Spain and Portugal, both key countries driving HPV testing growth in Europe. We look forward to bringing our HPV high-risk screening test to market in those countries through Inverness Medical this year.
“Third Wave is just as pleased to have secured Italian distribution of our HPV product through a team of outstanding and well-recognized regional distributors in that country,” Mr. Conroy said. “We continue to negotiate with potential distributors for each of the other major markets in Europe and look forward to having them in place soon.”
The company recently announced that its HPV high-risk screening test has achieved European CE Marking certification. The test detects the presence of 14 high-risk types of human papillomavirus, or HPV, the virus that causes nearly all cervical cancers. The test is used in the routine screening of women for cervical cancer.
Cervical cancer strikes nearly half a million women each year worldwide, claiming a quarter of a million lives, according to the National Cancer Institute.
For more information about Inverness Medical and its products, please visit the company's website at www.invernessmedical.es.
About Third Wave Technologies
Third Wave develops and markets molecular diagnostic reagents for a variety of DNA and RNA analysis applications to meet the needs of our customers. The company offers a number of products based on its Invader® chemistry for clinical testing. Third Wave offers in vitro diagnostic kits, and analyte specific, general purpose, and research use only reagents for nucleic acid analysis. For more information about Third Wave and its products, please visit the company's website at www.twt.com.
All statements in this news release that are not historical are forward-looking statements within the meaning of the Securities Exchange Act of 1934 as amended. Such forward-looking statements are subject to factors that could cause actual results to differ materially for Third Wave from those projected. Those factors include risks and uncertainties relating to the company's ability to bring new products to market as anticipated, the current regulatory environment in which the company sells its products, the market acceptance of those products, dependence on partners and customers, successful performance under collaborative and commercial agreements, competition, the strength of the Third Wave intellectual property, the intellectual property of others and other risk factors identified in the documents Third Wave has filed, or will file, with the Securities and Exchange Commission. Copies of the Third Wave filings with the SEC may be obtained from the SEC Internet site at http://www.sec.gov. Third Wave expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in Third Wave's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based. Third Wave Technologies, Invader and the Third Wave logo are trademarks of Third Wave Technologies, Inc.
Source: Third Wave Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.